Between-subject variability: should high be the new normal?

Hesham S. Al-Sallami; Song Lim Cheah; Shiou Yii Han; Joel Liew; Jin Lim; Mary Anne Ng; Hayneil Solanki; Run Jie Soo; Victoria Tan; Stephen B. Duffull

doi:10.1007/s00228-014-1740-8

Back

Between-subject variability: should high be the new normal?

Journal article

Peer reviewed

Between-subject variability: should high be the new normal?

Hesham S. Al-Sallami, Song Lim Cheah, Shiou Yii Han, Joel Liew, Jin Lim, Mary Anne Ng, Hayneil Solanki, Run Jie Soo, Victoria Tan and Stephen B. Duffull

European journal of clinical pharmacology, Vol.70(11), pp.1403-1404

01/11/2014

DOI: https://doi.org/10.1007/s00228-014-1740-8

Handle:

https://hdl.handle.net/10523/36907

Abstract

Life Sciences & Biomedicine

Pharmacology & Pharmacy

Science & Technology

Metrics

5 Record Views

27 Times Cited - Web of Science

Details

Record Identifier: 9926529191001891
Title: Between-subject variability: should high be the new normal?
Creators: Hesham S. Al-Sallami
Song Lim Cheah
Shiou Yii Han
Joel Liew
Jin Lim
Mary Anne Ng
Hayneil Solanki
Run Jie Soo
Victoria Tan
Stephen B. Duffull
Publication Details: European journal of clinical pharmacology, Vol.70(11), pp.1403-1404
Academic Unit: School of Pharmacy
Publisher: Springer Nature
Date published ; e-published: 01/11/2014
Language: English
Resource Type ; Subtype: Journal article

Between-subject variability: should high be the new normal?

Abstract

Related links

Metrics

Details